
With available labor resources dwindling and a shrinking pipeline, health systems must find creative solutions for better using the personnel and partnerships they have.
Leaders chime in on the benefits of the "buy and bill" model.
Date
January 26, 2022
By: MedSurg Editorial Team
Read time: 5 minutes
An alternative to the traditional "buy and bill" model of pharmaceutical distribution is bagging, which removes the financial burden from the provider because the specialty pharmacy or third-party payer must purchase the drug before it arrives in the provider's office. McKesson health systems leaders, Barbara Giacomelli and Valerie Russo provide insight on the benefits of the "buy and bill" model, and how to determine what's appropriate for your business.
With available labor resources dwindling and a shrinking pipeline, health systems must find creative solutions for better using the personnel and partnerships they have.
As payer dynamics shift, therapy pipelines grow, and leakage accelerates, health systems leaders should rethink what infusion care can and should be.
At this year's event, our experts heard from health systems who may be underutilizing available tools and resources in 340B program management.
Click through this interactive experience for a closer look at what you can expect at this year’s HealthTrust University Conference.
Our experts continue shaping industry conversations through regular conference and event engagements, like the HealthTrust University 340B Summit.
A recent podcast includes first-hand insights on opportunities for collaboration in strengthening the supply chain to achieve more.
This interactive experience highlights key aspects of our SPE solutions, designed to help your health system achieve more.
The first in a series of interviews with our Specialty Pharmacy Enablement expert, Ginger Thorpe, covering important questions health systems should be asking.